Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults

Схожі ресурси

• Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
  за авторством: Meyer, J, та інші
  Опубліковано: (2013)
• Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
  за авторством: Meyer, J, та інші
  Опубліковано: (2013)
• A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
  за авторством: Rowland, R, та інші
  Опубліковано: (2012)
• Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
  за авторством: Harris, S, та інші
  Опубліковано: (2013)
• Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
  за авторством: Pathan, A, та інші
  Опубліковано: (2012)